Abstract 2074: Adenosine-driven inflammatory reprogramming of aged cancer-associated fibroblasts promotes immune suppression in pancreatic ductal adenocarcinoma.

Abstract Background: Aging exerts a profound influence on the tumor immune microenvironment of pancreatic ductal adenocarcinoma (PDAC). In elderly patients, PDAC is frequently characterized by pronounced stromal desmoplasia, enhanced immune evasion, and increased resistance to chemotherapy. The molecular underpinnings of these age-associated alterations remain largely undefined. Emerging evidence indicates that aging-related metabolic reprogramming can profoundly reshape the cellular and immunologic composition of the tumor microenvironment (TME). Yet, the mechanistic interplay between metabolic perturbations, stromal cell dynamics, and immune regulation in aged PDAC has not been fully elucidated. Methods: Two PDAC clinical cohorts stratified by age and survival were analyzed using bulk and single-cell transcriptomics, and metabolomics. Nucleotide metabolism was assessed by targeted metabolomics. Functional studies included adenosine stimulation of aged and young cancer-associated fibroblasts (CAFs), B cell migration and co-culture assays, cytokine profiling, and orthotopic PDAC mouse models with adenosine receptor blockade. Multiplex immunohistochemistry (mIHC) was applied to spatially validate the proximity of A2B+CXCL13+ CAFs and IL-10+ Bregs in aged human PDAC tissues. Results: Aged PDAC exhibited increased regulatory B (Breg) cell abundance, which correlated with shorter overall survival. Multi-omic analyses identified age-related adenosine accumulation as the most dysregulated metabolite linked to both poor prognosis and Breg infiltration. Direct adenosine exposure failed to expand Bregs but reprogrammed aged CAFs toward a proinflammatory state. Aged CAFs expressed elevated adenosine receptor A2B and secreted the B cell chemoattractant CXCL13 upon adenosine stimulation. The adenosine-A2B-CXCL13 axis promoted IL-10+ Breg recruitment, which suppressed CD8+ T cell cytotoxicity and accelerated tumor growth. mIHC confirmed close spatial association between CXCL13+ CAFs and Bregs within aged PDAC tissues. Pharmacologic inhibition of A2B signaling or CXCL13 neutralization reduced Breg infiltration, restored T cell activity, and prolonged survival in orthotopic aged PDAC models. Conclusion: Age-associated adenosine accumulation reshapes the fibroblastic niche through A2B receptor-dependent inflammatory reprogramming, inducing CXCL13-mediated Breg recruitment and immune suppression. Targeting the adenosine-A2B-CXCL13 axis represents a promising strategy to restore anti-tumor immunity in elderly patients with PDAC. Citation Format: Shuncang Zhu, Jinpeng Lu, Ziyi Tu, Hongyi Lin, Yinhao Chen, Yiting Chen, Haoxiang Zhang, Zuwei Wang, Shi Chen. Adenosine-driven inflammatory reprogramming of aged cancer-associated fibroblasts promotes immune suppression in pancreatic ductal adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2074.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-2074
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 2074: Adenosine-driven inflammatory reprogramming of aged cancer-associated fibroblasts promotes immune suppression in pancreatic ductal adenocarcinoma.

Shuncang Zhu, Shi Chen, Haoxiang Zhang, Zuwei Wang et al.
Cancer Research
Cancer Research and Treatments
article

Abstract 2074: Adenosine-driven inflammatory reprogramming of aged cancer-associated fibroblasts promotes immune suppression in pancreatic ductal adenocarcinoma.

Shuncang Zhu, Shi Chen, Haoxiang Zhang, Zuwei Wang, Jinpeng Lu, Yiting Chen, Yinhao Chen, Hongyi Lin, Ziyi Tu
article en

Abstract

Abstract Background: Aging exerts a profound influence on the tumor immune microenvironment of pancreatic ductal adenocarcinoma (PDAC). In elderly patients, PDAC is frequently characterized by pronounced stromal desmoplasia, enhanced immune evasion, and increased resistance to chemotherapy. The molecular underpinnings of these age-associated alterations remain largely undefined. Emerging evidence indicates that aging-related metabolic reprogramming can profoundly reshape the cellular and immunologic composition of the tumor microenvironment (TME). Yet, the mechanistic interplay between metabolic perturbations, stromal cell dynamics, and immune regulation in aged PDAC has not been fully elucidated. Methods: Two PDAC clinical cohorts stratified by age and survival were analyzed using bulk and single-cell transcriptomics, and metabolomics. Nucleotide metabolism was assessed by targeted metabolomics. Functional studies included adenosine stimulation of aged and young cancer-associated fibroblasts (CAFs), B cell migration and co-culture assays, cytokine profiling, and orthotopic PDAC mouse models with adenosine receptor blockade. Multiplex immunohistochemistry (mIHC) was applied to spatially validate the proximity of A2B+CXCL13+ CAFs and IL-10+ Bregs in aged human PDAC tissues. Results: Aged PDAC exhibited increased regulatory B (Breg) cell abundance, which correlated with shorter overall survival. Multi-omic analyses identified age-related adenosine accumulation as the most dysregulated metabolite linked to both poor prognosis and Breg infiltration. Direct adenosine exposure failed to expand Bregs but reprogrammed aged CAFs toward a proinflammatory state. Aged CAFs expressed elevated adenosine receptor A2B and secreted the B cell chemoattractant CXCL13 upon adenosine stimulation. The adenosine-A2B-CXCL13 axis promoted IL-10+ Breg recruitment, which suppressed CD8+ T cell cytotoxicity and accelerated tumor growth. mIHC confirmed close spatial association between CXCL13+ CAFs and Bregs within aged PDAC tissues. Pharmacologic inhibition of A2B signaling or CXCL13 neutralization reduced Breg infiltration, restored T cell activity, and prolonged survival in orthotopic aged PDAC models. Conclusion: Age-associated adenosine accumulation reshapes the fibroblastic niche through A2B receptor-dependent inflammatory reprogramming, inducing CXCL13-mediated Breg recruitment and immune suppression. Targeting the adenosine-A2B-CXCL13 axis represents a promising strategy to restore anti-tumor immunity in elderly patients with PDAC. Citation Format: Shuncang Zhu, Jinpeng Lu, Ziyi Tu, Hongyi Lin, Yinhao Chen, Yiting Chen, Haoxiang Zhang, Zuwei Wang, Shi Chen. Adenosine-driven inflammatory reprogramming of aged cancer-associated fibroblasts promotes immune suppression in pancreatic ductal adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2074.

Cancer ResearchVol. 86(7_Supplement)
Fujian Medical University (CN), University of Kentucky (US), Fujian Provincial Hospital (CN), Fuzhou University (CN)
Good health and well-being
Openalex Percentile: Top 8%
Cancer Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.